The Latest in Gastrointestinal Cancer

Are Targeted Drugs the Future in Colorectal Cancer?

October 8, 2024

FDA OKs Next-Gen Cologuard Test for CRC Screening

October 4, 2024

NCCRT Confirmed as Best Approach in Locally Advanced, Resectable ESCC

October 3, 2024

FDA Panel Votes for Limits on Gastric, Esophageal Cancer Immunotherapy

September 30, 2024

Sex and Gender Influence Outcomes in Colorectal Cancer

September 27, 2024

Survival Outcomes in Hepatocellular Carcinoma Patients Show Improvement Over Time

September 26, 2024

Does Medicare Advantage Offer Higher-Value Chemotherapy?

September 26, 2024

AACR Cancer Progress Report: Big Strides and Big Gaps

September 26, 2024

Cancer Risk: Are Pesticides the New Smoking?

September 20, 2024

A CRC Blood Test Is Here. What Does it Mean for Screening?

September 20, 2024

Fecal Immunochemical Test Performance for CRC Screening Varies Widely

September 19, 2024

A Simple Blood Test May Predict Cancer Risk in T2D

September 11, 2024

Five Key Measures to Ensure a Quality Colonoscopy

September 10, 2024

KRAS Inhibitors in Pancreatic Cancer: Hope on the Horizon?

September 9, 2024

Do Clonal Hematopoiesis and Mosaic Chromosomal Alterations Increase Solid Tumor Risk?

September 6, 2024